| 10865404 |
Aspartase mutant, recombinant expression vector and recombinant bacterium containing aspartase mutant, and use thereof |
Zhiming Rao, Jiamin Chen, Taowei Yang, Meijuan Xu, Xian Zhang +5 more |
2020-12-15 |
| 10526611 |
Gene targeting using mutant Agrobacterium strains |
Stanton B. Gelvin, Lan-Ying Lee |
2020-01-07 |
| 8637449 |
Processes for preparing protease inhibitors of hepatitis C virus |
Zhiguo Jake Song, David M. Tellers, Laura Artino, David R. Lieberman |
2014-01-28 |
| 8507504 |
Process for producing bicycloaniline derivatives |
Shuntaro Furukawa, Taketo Ikeno, Shinji Kato, Masashi Kawasaki, Hisaki Kojima +4 more |
2013-08-13 |
| 7893081 |
Tyrosine kinase inhibitors |
Paolo Avalle, Jennifer R. Foley, Peter Richard MULLENS, Peter Yehl |
2011-02-22 |
| 7700611 |
Synthesis and crystalline forms of NPY5 antagonist |
Russell R. Ferlita, Yuji Haga, Makoto Ishikawa, Keisuke Kamei, Shinji Kato +8 more |
2010-04-20 |
| 7629470 |
Formation of tetra-substituted enamides and stereoselective reduction thereof |
Kevin R. Campos, Artis Klapars, J. Christopher McWilliams, C. Scott Shultz, Debra Jane Wallace +5 more |
2009-12-08 |
| 7074930 |
Amine salts of an integrin receptor antagonist |
Kenneth M. Wells, Nobuyoshi Yasuda |
2006-07-11 |
| 6509347 |
Crystalline forms of an integrin receptor antagonist |
Wei Xu |
2003-01-21 |
| 6407241 |
Process and intermediates for the preparation of imidazolidinone &agr;v integrin antagonists |
Mark S. Jensen, Michael Palucki, Nelo Rivera, Kenneth M. Wells, Yi Xiao +2 more |
2002-06-18 |
